Contrast-enhanced voiding urosonography (ceVUS) has been recognized as a child-friendly examination with high diagnostic accuracy for vesicoureteric reflux detection. A single bolus and the infusion techniques of ceVUS are described. Insufficient bladder contrast opacification during the filling phase and premature destruction of SonoVue microbubbles might occur. Data regarding SonoVue's features, doses, bladder contrast opacification, US bladder parameters, urine catheter, antibiotic prophylaxis, and childrens behaviors were collected to discover the possible causes of the contrast vanishing observed during bladder filling in 10% of examinations and in the later phase of ceVUS in 5% of examinations. An updated ceVUS examination protocol is suggested. and Lumason (USA) (Bracco, Milan, Italy) were approved for intravesical use in children in 2017. The high-safety profile of the intravesical application was confirmed in studies in which fewer than 1% of more than 7000 children examined suffered from minor adverse events that were related to the bladder catheterization rather than to the UCA.
| INTRODUCTION
Contrast-enhanced voiding urosonography (ceVUS) has been shown to play an important role in urologic imaging for the detection of vesicoureteric reflux (VUR) and recently for urethra evaluation. [1] [2] [3] The main ingredient of second-generation ultrasound contrast agents (UCAs) is an inert, stable gas that is encapsulated by a shell made of phospholipids, lipids or serum albumin. UCA sulfur hexafluoride lipidtype A microspheres with the commercial names SonoVue (Europe) and Lumason (USA) (Bracco, Milan, Italy) were approved for intravesical use in children in 2017. The high-safety profile of the intravesical application was confirmed in studies in which fewer than 1% of more than 7000 children examined suffered from minor adverse events that were related to the bladder catheterization rather than to the UCA. [4] [5] [6] The ceVUS procedure is well standardized and described by the European Society of Pediatric Radiology Uroradiology task force, and its diagnostic accuracy is well documented. [7] [8] [9] In addition, an in vitro evaluation of the second-generation UCA for the in vivo optimization of ceVUS has been published. 10 In our hospital, ceVUS is performed using standard ultrasound (US) machine contrast-specific settings, with a mechanical index (M.I.) below 0.1, and bladder continuous infusion techniques using a mixture of SonoVue and saline solution. However, premature destruction of contrast microbubbles during ceVUS has been observed in our everyday clinical practice. To our knowledge, only one published study has addressed this problem thus far. 11 The purpose of this manuscript is to present our long-term practice in the ceVUS field using SonoVue, the possible causes of the premature microbubble destruction and whether extra caution should be used to minimize the possibilities of contrast vanishing due to premature microbubble destruction, thus avoiding false-negative results.
| MATERIALS AND METHODS
CeVUS was performed in 163 children from April to December 2016, and the examinations were retrospectively evaluated. In 58 children, some of the necessary data were missing, and in 2 of them, adisagreement was noted between the written information and the stored images. Therefore, 105 examinations performed on 45 boys and 60 girls, aged from 2 weeks to 10.3 years (mean 2.7 years), were retained for further evaluation. In each child, US and ceVUS were performed according to the following accepted indications for this examination in our hospital: a proven febrile urinary tract infection (n = 17), urinary tract infection and abnormal US (n = 28), recurrent urinary tract infections (n = 18), abnormal US without urinary tract infection (n = 15), follow-up of a previously detected VUR (n = 12), follow-up after endoscopic or surgical treatment (n = 11), bacteriuria (n = 2), and other indications (n = 2). Written informed consent was obtained from the parents before the examination after they were provided an explanation of the procedure.
All of the children had a normal urine analysis and a negative urine culture. They received a single therapeutic dose of an antibiotic on the day of the examination.
First, a baseline grayscale US of the urinary tract was performed using an Aplio XL US machine (Toshiba, Tokyo, Japan) with a 2.5-5 MHz convex probe and a 7.5 MHz microconvex probe. The renal parenchyma, pelvicalyceal system, bladder and ureters were examined. A predicted bladder volume (V p ) was calculated according to the following formulas: bladder volume (in ml) = weight (in kg) × 10 during the the first year of life and bladder volume (in ml) = (age [in years] +2) × 30 afterward. The actual bladder volume (V a ) was compared to the Vp. The ratio Va/Vp was determined to be ≤1 for a bladder filled up to the predicted volume and > 1 for an overfilled bladder. CeVUS was performed only with a 2.5-5 MHz probe using contrast-specific software. The mechanical index was set below 0.1).
In all children, the same type of bladder catheter was used; however, the sizes ranged from 6 to 10 F. The time elapsed between the UCA reconstitution and its administration was recorded. CeVUS was performed by the continuous infusion technique into the previously emptied urinary bladder. UCA SonoVue was mixed with a prewarmed saline solution in a plastic bottle, which was connected to the urine catheter via the same type of drip system and placed approximately 1 m above the examination table. All UCA vials from 3 different lots were stored in the same place and used before the expiration date. A cyclic procedure was performed if VUR was not detected during the first cycle. Solutions of 0.2-0.5 ml contrast/100 ml saline, 0.5-1 ml/250 ml, and 1 ml/500 ml were used in 90% of the children.
In 10% of the children, a higher dose was administered at the examiner's discretion.
The time elapsed between the UCA reconstitution and its administration (in minutes) and the amount of UCA administered (ml of SonoVue/ml saline) were recorded. The contrast opacification of the bladder (initial and during the examination) was determined to be insufficient (too low of a contrast opacification in the bladder with too few microbubbles) ( Figure 1A ), satisfactory (uniform distribution of microbubbles in the bladder with a visualization of the posterior bladder wall and retrovesical space) ( Figure 1B ), or too high (impossible to identify the posterior bladder wall and retrovesical space) ( Figure 1C ). The dose of UCA in ml (used for initial or repeat administration) was recorded.
Observation of the children included grading the crying (1 − none to moderate crying, 2 − intense crying) and grading the muscle tonus
(1 − normal to moderately increased muscle tonus, 2 − extremely elevated muscle tonus preventing movement of the legs and making the transperineal US approach impossible). In addition, voiding difficulties during the examination were recorded.
Statistical analyses were performed using SPSS 21.0 (SPSS, 
| RESULTS
Data from 105 ceVUS examinations were evaluated. In total, 87 (82.8%) children had normal contrast opacification of the urinary tract during the examination, while premature microbubble destruction occurred at various times during the examination in 18 (17.2%) subjects. This premature microbubble destruction occurred during the filling phase of the bladder within the first 2 minutes in 13/18 patients (overall incidence, 12.4%) and after more than 5 minutes during the course of the examination in 5/18 patients (overall incidence, 4.8%) ( Table 1) . No side effects related to the intravesical contrast administration were observed.
There was a major drop out due to insufficient recording data involving 58 children. Of the 163 examinations analyzed, 12.3% of the children had insufficient bladder opacification compared to 17.2% of children with complete recorded data. Only 2/58 subjects had insufficient bladder opacification, but inconsistencies were found between the written information and the stored images, while 56 subjects had normal bladder opacification throughout the entire examination.
| Contrast opacification related to the contrast agent SonoVue
The initial contrast opacification of the bladder during the filling phase was unsatisfactory in 13/105 children, satisfactory in 76 children, and too strong in 16 children. All children with insufficient contrast opacification required an additional contrast dose between 0.2 and 0.5 ml;
in 12 subjects, the dose was administered in a bolus directly via the urinary catheter, and one dose of 0. (Table 1) . However, in 10 children the contrast was administered more than 2 hours after the initial reconstitution, and in 4 of them (40%), premature microbubble destruction occurred during the filling phase.
| Contrast opacification related to the urine catheter
Only one type of urine catheter was used but with 3 different sizes; a 6 F catheter was used in 40 children (38.1%), a 8 F catheter was used in 60 children (57.1%), and a 10 F urine catheter was used in 5 children The size of the urine catheter was not a statistically significant parameter according to the Kruskal-Wallis test (Table 2 ).
| Contrast opacification related to the bladder parameters
In total, 78/105 children had a normal bladder US without ureteral distension. In 27/105 children (25.7%), other abnormalities of the bladder and ureters were described; 14 had prevesical dilation of the ureter(s) and a normal bladder, 2 had a prevesical dilation and a thickened bladder wall, 1 had a thickened bladder wall, 8 had residuals around the ureter ostia that were observed after endoscopic or surgical procedures (one of them had also a prevesical ureter dilatation), and 2 had US signs of a neurogenic bladder. These abnormal US findings had no influence on the contrast opacification of the bladder or premature microbubble destruction ( Table 1) . Analysis of the Va/Vp ratio during the examination showed that 99 children exhibited bladder filling to a predicted ratio (Va/Vp ≤ 1), and 6 children exhibited bladder overfilling (Va/Vp >1). Bladder overfilling was found to be a statistically significant parameter that contributed to microbubble destruction (P < .001).
In half of the children with an overfilled bladder, the contrast vanished after 5-13 minutes. The bladder was not emptied enough prior to the contrast administration in 6/18 children with contrast vanishing. If the contrast was readministered into the overfilled bladder, microbubble destruction occurred in less than 2 minutes. We found that concomitant drugs were used in only 10% of children without any noticeable influence on the contrast opacification.
| Contrast opacification related to the children's behavior
According to the crying grading system, 96/105 children did not cry or cried moderately, and 9 cried intensely. The muscle tonus was graded normal or moderately increased in 99/105 children and extremely increased in 6 children (premature microbubble destruction occurred at more than 5 minutes after the contrast administration in 3 of the 6 children).
The children's behavior parameters and their crying and muscle tonus grades were statistically significant causes related to microbubble destruction, especially the combination of intense crying with extremely elevated muscle tonus (Table 2) . Three children had voiding problems, and premature microbubble destruction occurred in all of them.
| DISCUSSION
CeVUS has been recognized as a child-friendly examination with a high diagnostic accuracy and a safety profile. Two contrast administration techniques have been suggested: a single bolus and an infusion technique ( Table 2) . 8 The single bolus technique was initially used in our department, but we have as switched to the infusion technique because the initial bladder contrast opacification was often too high and thus obscured the retrovesical area. In addition, the children were frightened by the manipulation of the urine catheter during the bolus application.
As the introduction of the infusion technique, premature microbubble destruction has been observed during our daily routine work. Two events of premature microbubble destruction were also reported to the manufacturer (Bracco), and both vials were sent for analysis. The results of the analysis showed no differences regarding the quality of the contrast agent. We aimed to investigate the possible reasons for insufficient bladder opacification and premature microbubble destruction.
Our study showed that insufficient contrast opacification could occurrat the beginning of the examination during the filling phase but also later in the phase of ceVUS. Bladder overfilling, increased muscle tonus and crying were found to be statistically significant causes of premature microbubble destruction in our study group. Although Furthermore, great caution should be taken during the reconstitution of UCA when it is used more than 2 hours after the first reconstitution, even though the chemical and physical stability of the microbubble dispersion has been demonstrated for 6 hours after the first contrast reconstitution. 10, 12 The size of the urine catheter was shown to be a statistically insignificant parameter regarding microbubble destruction. The diameter of the 6 F catheter is comparable to that of a 13-14 gauge needle, which is considered to be risk-free for contrast breakage. 14, 15 However, in combination with other factors, the catheter diameter may contribute to the premature destruction of microbubbles. It is also important to empty the bladder before the contrast infusion; the inflow of the contrast infusion into an insufficiently emptied bladder might contribute to higher bladder pressure at an early point during the course of the examination. In addition, the influence of urine osmolality in premature microbubble destruction is not known and should be investigated.
11
A major pitfall of this study is that the temperature of the contrast and saline solution mixture was not recorded. in vitro studies showed that a temperature-mediated increase in the microbubble diameter was the dominant cause of decreased bubble stability. 16 At body temperature, microbubbles exhibit greater radial excursion and oscillate less spherically with a greater incidence of jetting and gas expulsion and therefore collapse more than they do at room temperature. 17 If the exact temperature of the contrast solution cannot be monitored, using a saline solution at room temperature is recommended. Consistent with the results of our study, one possible explanation is the exposure of the microbubbles to increased pressure in the bladder of a crying child or a child with impaired micturition. Intense crying, increased muscle tonus and bladder overfilling, which could all elevate the intravesical and/or intraabdominal pressure, were statistically significant factors for premature microbubble destruction. However, the actual bladder or abdominal pressure was not measured.
The sample size was too small to provide any firm conclusion, but it appears that a combination of multiple factors contributes to premature microbubble destruction. 11 The incidence of premature microbubble destruction in our study was 5%, which is slightly lower than that reported by Piskunowicz et al.
The possible factors contributing to premature microbubble destruction and recommended actions are listed in Table 3 . If insufficient contrast opacification is observed during the filling phase of ceVUS, the infusion should be stopped immediately, the bladder volume checked, the vial with UCA reconstituted, the agent readministered (dose 0.2-0.5 ml) directly into the bladder or into the bottle of the contrast and saline mixture, and the procedure continued. If insufficient contrast opacification is observed later in the course of the examination, the bladder volume should be checked, the child calmed to reduce crying and muscle tonus, and encouraged to void. If the bladder is overfilled, it should be emptied before the repeat administration of contrast agent.
| CONCLUSION
Insufficient bladder opacification during ceVUS using the infusion technique occurs infrequently. Attention should be paid first to proper UCA preparation and administration, second, to the contrast opacification of the bladder throughout the entire ceVUS examination, taking care not to overfill the bladder, and third, to the creation of a child-friendly environment. Larger studies are needed to evaluate the influence of bladder pressure on premature microbubble destruction and to identify other possible factors. 
